These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 4296871)

  • 21. Inactivated vaccines based on alternatives to wild-type seed virus.
    Chumakov K; Dragunsky E; Ivshina A; Enterline J; Wells V; Nomura T; Gromeier M; Wimmer E
    Dev Biol (Basel); 2001; 105():171-7. PubMed ID: 11763325
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the neurovirulence test of poliomyelitis-live vaccine. V. A statistical method for the evaluation of the experiment for the comparison of neurovirulence in the monkey].
    Seinsche D; Bonin O; Unterharnscheidt F; Schmidt K; Schmidt I
    Arch Psychiatr Nervenkr (1970); 1966; 208(5):433-46. PubMed ID: 4291066
    [No Abstract]   [Full Text] [Related]  

  • 23. Virologic control of monkeys used for the production of poliomyelitis virus vaccine.
    Osterhaus AD; van Steenis G
    Dev Biol Stand; 1981; 47():157-61. PubMed ID: 6785124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited in vivo susceptibility of the South American monkey -Cebus apella- to type 1 poliovirus: physical and histopathological observations after intraspinal inoculation.
    Abe S; Doi Y; Marchevsky RS; Leal MD; Homma A
    Biken J; 1985 Jun; 28(1-2):21-30. PubMed ID: 3000348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The production of inactivated poliovaccine on serially cultivated kidney cells from captive-bred monkeys.
    van Wezel AL; van der Velden-de Groot CA; van Herwaarden JA
    Dev Biol Stand; 1980; 46():151-8. PubMed ID: 6244995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gaps in scientific knowledge for the post eradication world.
    Minor P
    Biologicals; 2006 Jun; 34(2):167-70. PubMed ID: 16678439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the neurovirulence test of poliomyelitis-live vaccine. V. A statistical method for the evaluation of the experiment for the comparison of neurovirulence in the monkey].
    Seinsche D; Bonin O; Unterharnscheidt F; Schmidt K; Schmidt I
    Arch Psychiatr Nervenkr (1970); 1966; 208(5):433-46. PubMed ID: 4291332
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study of the biological properties of vaccinal strains of type 3 poliomyelitis virus isolated from children in Sverdlovsk].
    Shchekochikhina EA; Dodonova NN; Dzagurov SG; Omel'chenko TN; Tsetlin EM
    Vopr Virusol; 1973; 18(4):484-9. PubMed ID: 4362265
    [No Abstract]   [Full Text] [Related]  

  • 29. The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine.
    Montagnon BJ; Fanget B; Nicolas AJ
    Dev Biol Stand; 1981; 47():55-64. PubMed ID: 6785126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [STUDIES ON TESTS FOR THE NON-TOXICITY OF INACTIVATED POLIOMYELITIS VACCINES. 1. INFLUENCE OF MAGNESIUM CHLORIDE ON THE SUSCEPTIBILITY OF MONKEY KIDNEY CELL CULTURES TO FORMALIN-TREATED POLIOMYELITIS VIRUS].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Nov; 190():313-21. PubMed ID: 14105973
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.
    Bull World Health Organ; 1969; 40(6):925-45. PubMed ID: 4310724
    [No Abstract]   [Full Text] [Related]  

  • 32. A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine.
    Wood DJ; Heath AB; Kersten GF; Hazendonk T; Lantinga M; Beuvery EC
    Biologicals; 1997 Mar; 25(1):59-64. PubMed ID: 9167009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys.
    Rumyantsev AA; Chanock RM; Murphy BR; Pletnev AG
    Vaccine; 2006 Jan; 24(2):133-43. PubMed ID: 16115704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Several virologic and biochemical aspects of vaccination with antipoliomyelitis vaccine. Fate of the parent virus].
    Kiselev FL; Sadogurskaia EM; Gorshunova LP
    Vopr Virusol; 1977; (2):184-9. PubMed ID: 197713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of immunosuppression on morphological changes in CNS of monkeys infected with different measles virus vaccine strains.
    Sharova OK; Rozina EE; Gordienko NM; Shteinberg LS
    Acta Virol; 1984 Mar; 28(2):144-7. PubMed ID: 6145348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on variants of poliomyelitis virus. I. Experimental segregation and properties of avirulent variants of three immunologic types.
    SABIN AB; HENNESSEN WA; WINSSER J
    J Exp Med; 1954 Jun; 99(6):551-76. PubMed ID: 13163327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On the patomorphology and histochemistry of poliomyelitis in children vaccinated with Salk vaccine].
    ERMAN BA; MYL'NIKOVA NE
    Arkh Patol; 1961; 23(12)():11-6. PubMed ID: 13890618
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prerequisites for neurovirological and neurotoxicological tests in animal experiment].
    Glees P
    Dtsch Med Wochenschr; 1968 Dec; 93(49):2383-6 passim. PubMed ID: 4301399
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety and immunogenicity of a booster dose of inactivated poliovirus vaccine produced in vero-cells.
    Haastrup E; Thierry-Carstensen B; Jensen AM; Stellfeld M; Heilmann C
    Vaccine; 2004 Feb; 22(8):958-62. PubMed ID: 15161072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Midbrain and spinal cord magnetic resonance imaging (MRI) changes in poliomyelitis.
    Choudhary A; Sharma S; Sankhyan N; Gulati S; Kalra V; Banerjee B; Kumar A
    J Child Neurol; 2010 Apr; 25(4):497-9. PubMed ID: 20139405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.